Meningitis in Children

Last updated: April 1, 2026

Meningitis in Children

Meningitis is a life-threatening infection of the meninges.

Definition of terms

TermDefinition
Acute bacterial meningitisRapid onset of symptoms. Can be identified using routine laboratory techniques.
Chronic meningitisOngoing symptoms of meningitis for ≥ 4 weeks without clinical improvement
Aseptic meningitisThe symptoms of meningitis are present without evidence of bacterial cause by usual laboratory testing methods. It includes viruses, Mycobacterium tuberculosis, Borrelia burdgoferi, and non-infectious causes.

Common organisms

AgeCommon organisms
< 28 daysGBS, Escherichia Coli, Enterobacter, Listeria monocytogenes
28 days – 3 monthsEscherichia coli, GBS, S. pneumoniae, H. influenzae, N. meningitidis, Listeria monocytogenes
3 months – 18 yearsN. meningitidis, S. pneumoniae, H. influenzae
  • Risk factors in neonates
    • Preterm
    • Low birth weight
    • Chorioamnionitis
    • Endomeritis
    • Maternal GBS colonization
    • Prolonged duration of intrauterine monitoring ( > 12 hours)
    • PROM
    • Traumatic delivery
    • Fetal hypoxia
    • Galactosemia
    • Urinary tract abnormalities
    • Dermal sinus tract of the spine
  • Risk factors in children
    • Asplenia (functional or anatomic)
    • Primary immunodeficiency
    • HIV infection
    • Sickle cell anemia (functional asplenia)
    • Cochlear implant
    • CSF leak
    • Recent upper respiratory tract infection
    • Day care attendance
    • Lack of breastfeeding
    • Exposure to a case of meningococcal or HiB meningitis
    • Penetrating head trauma
    • Dermal sinus tract of the spine
    • Travel to an area with endemic meningococcal disease
    • Lack of immunization
  • Signs and symptoms in younger children (non-specific)
    • Temperature instability (Fever OR Hypothermia)
    • Lethargy OR Irritability (fussy, inconsolable cry, sleepy, weak, or jittery)
    • Poor feeding
    • Vomiting
    • Apnea
    • Convulsions (not always present)
    • Bulging fontanelle
    • Poor tone
  • Signs and symptoms in older children
    • Fever
    • Headache
    • Anorexia
    • Nausea, Vomiting
    • Photophobia
    • Confusion
  • Physical exam findings due to meningeal irritation (meningism)
    • Neck stiffness
    • Opisthotonus
    • Positive Kernig
    • Positive Brudzinski sign
    • Focal neurological deficits
      • Suggests localized infarction and subdural collection
      • Cranial nerve palsies are commonly seen in tuberculous meningitis and cryptococcal meningitis
  • Differentials for meningeal irritation (Meningism)
    • Strep throat (URTI)
    • Pneumonia
    • Pyelonephritis
    • Intracranial bleeding (Subarachnoid hemorrhage)
    • Cerebral infarction
    • Vasculitis
  • Investigations
    • Lumbar Puncture for CSF analysis: CSF should ideally be obtained before starting antibiotics. Pre-treatment with antibiotics might decrease the likelihood of positive CSF culture, but does not adversely affect CSF cell counts.
      • WBC count
      • Differential count
      • Protein level
      • Gram stain
      • Culture
    • Blood Culture
    • Complete Blood Count
    • C-reactive protein: elevated. Serial CRP to monitor clinical response and screen for complications
    • Procalcitonin: elevated
    • U/E/Cs
    • Random Blood Sugar: to rule out hypoglycemia
    • Urinalysis and Urine Culture
    • PCR
    • CT scan or MRI: if there are focal neurological deficits
    • Cranial ultrasound: for neonates
  • Supportive Treatment
    • Treat dehydration and prevent overhydration
    • Manage blood sugar level
    • Treat convulsions
    • Treat fever and pain
    • Monitor vital signs
    • Measure head circumference daily for < 18 months (1.5 years)
  • Definitive Treatment
    • Intravenous ceftriaxone
      • 14 days for uncomplicated meningitis d/t GBS, L. monocytogenes, or S. pneumoniae
      • 21 days for uncomplicated meningitis due to Gram-negative bacilli)
      • Not recommended for jaundiced neonates or neonates ≤ 6 days
    • Dexamethasone for HiB meningitis
      • Infants and children < 6 weeks of age and older (considering possible risks vs potential benefits)
      • Reduces the incidence of hearing loss
  • Preventative Treatment
    • Hib vaccine (integrated in Nov 2001)
    • Pneumococcal Vaccine (integrated into KEPI 2010, PCV10)
    • Meningococcal Vaccine (introduced 2019; Menactra, Nimerix): Turkana, Marsabit, Mandera, West Pokot, and Wajir
  • Suppurative complications
    • Subdural empyema
    • Pleural empyema
    • Arthritis
    • Pericarditis
    • Ventriculitis
    • Brain abscess
  • Neurological complications
    • Hearing loss (20-30% w/ pneumococcal, 10% w/ meningococcal, 5% with HiB)
    • Cognitive and developmental disability
    • Hemiparesis
    • Quadriparesis
    • Cranial nerve palsies
    • Epilepsy
    • Cortical blindness
    • Hydrocephalus
    • Diabetes insipidus
    • Hypothalamic dysfunction
  • Prognosis
    • A decreased level of consciousness at presentation is associated with an increased risk of death and neurological sequelae
    • Development of seizures > 72 hours after starting antibiotics is associated with learning difficulties
    • S. pneumoniae has a relatively poorer outcome compared to HiB or N. meningitidis

ETAT+

DiagnosisFeatures
Definite meningitisCloudy CSF tap AND/OR, WBC > 10 x 10^6/L; Gram-positive diplococci or Gram-negative cocco-bacilli
Probable MeningitisComa, Stiff neck, bulging fontanelle, Clear CSF
Possible meningitisCSF WBC and Gram stain results not done, No coma/stiff neck/bulging fontanelle/clear CSF
Complicated meningitisSubdural empyema, Ventriculitis, Brain abscess, Suppurative venous sinus thrombosis
  • When do we ABSOLUTELY need to perform LP (unless contraindications)
    • Coma
    • Inability to drink/feed
    • AVPU = ‘P or U’
    • Bulging fontanelle
    • Convulsions if age < 6 months or > 6 years
    • Evidence of partial seizures
  • When do we need to perform LP (unless completely normal mental state after febrile convulsion)
    • Agitation or Irritability
    • Any convulsions
    ***Review after 8 hours and repeat LP if doubt persists
  • Absolute contraindications to Lumbar Puncture (CT/MRI findings)
    • Midline shift
    • Posterior fossa mass (common in HIE)
    • Loss of cisterns
  • When to defer a Lumbar Puncture (relative contraindications)
    • Shock or Cardiovascular instability
    • Signs of raised ICP (Bradycardia, Hypertension, irregular respirations)
    • Focal neurological deficits (Poor pupillary response to light, etc.)
    • Focal seizures
    • Infection of the skin at the LP site
    • Evidence of coagulopathy (esp. in meningococcal septicemia)
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *